• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

    1.970 +0.020 (+1.03%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 10,872,028
    Open 1.970
    Bid (Size) 1.950 (28)
    Ask (Size) 1.980 (1)
    Prev. Close 1.950
    Today's Range 1.940 - 2.000
    52wk Range 1.639 - 12.51
    Shares Outstanding 305,252,194
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
    Via Investor Brand Network
    IOVANCE INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Long-Term Iovance, Inc. Stockholders
    From Bragar Eagel & Squire
    Via GlobeNewswire

    Performance

    YTD
    -74.7%
    -74.7%
    1 Month
    -10.9%
    -10.9%
    3 Month
    -26.5%
    -26.5%
    6 Month
    -43.7%
    -43.7%
    1 Year
    -81.1%
    -81.1%

    More News

    Read More
    Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’
    Via Stocktwits
    Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
    Via FinancialNewsMedia
    Adaptimmune Plunges After Announcing Nasdaq Delisting Amidst Compliance Failures and Cost-Cutting Measures
    Via MarketMinute
    Topics Initial Public Offering Regulatory Compliance Workforce
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    Turnstone Biologics: A $100 Dream Collides with a $0.34 Reality
    Via MarketMinute
    Topics Intellectual Property Workforce
    Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health
    Via The Motley Fool
    Is Iovance Biotherapeutics Stock Your Ticket to Becoming a Millionaire?
    Via The Motley Fool
    IOVANCE (IOVA) ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Iovance Biotherapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    Can This Beaten-Down Stock Bounce Back?
    Via The Motley Fool
    Advancing Cancer Research Brings New Hope for Patients Worldwide
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    Advancing Cancer Research Brings New Hope for Patients Worldwide
    Via FinancialNewsMedia
    Topics Artificial Intelligence Intellectual Property
    Iovance Biotherapeutics to Present at Upcoming Conferences
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    If You'd Invested $1,000 in IOVA 3 Years Ago, Here's How Much You'd Have Today
    Via The Motley Fool
    Why Iovance Biotherapeutics Stock Got Mashed on Monday
    Via The Motley Fool
    Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    1 Beaten-Down Stock That Could Soar By 261%, According to Wall Street
    Via The Motley Fool
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    From Iovance Biotherapeutics, Inc.
    Via GlobeNewswire
    Why Iovance Biotherapeutics Stock Was Climbing Today
    Via The Motley Fool
    Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Frequently Asked Questions

    Is Iovance Biotherapeutics, Inc. - Common Stock publicly traded?
    Yes, Iovance Biotherapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Iovance Biotherapeutics, Inc. - Common Stock trade on?
    Iovance Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Iovance Biotherapeutics, Inc. - Common Stock?
    The ticker symbol for Iovance Biotherapeutics, Inc. - Common Stock is IOVA on the Nasdaq Stock Market
    What is the current price of Iovance Biotherapeutics, Inc. - Common Stock?
    The current price of Iovance Biotherapeutics, Inc. - Common Stock is 1.970
    When was Iovance Biotherapeutics, Inc. - Common Stock last traded?
    The last trade of Iovance Biotherapeutics, Inc. - Common Stock was at 10/31/25 04:00 PM ET
    What is the market capitalization of Iovance Biotherapeutics, Inc. - Common Stock?
    The market capitalization of Iovance Biotherapeutics, Inc. - Common Stock is 601.35M
    How many shares of Iovance Biotherapeutics, Inc. - Common Stock are outstanding?
    Iovance Biotherapeutics, Inc. - Common Stock has 601M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.